10-Q Filing

IMMIX BIOPHARMA, INC. CIK: 1873835 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001493152-22-013365`
Period End Date	20220331
Filing Date	20220513
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 51 Income Statement 30 Cash Flow Statement 54 Stockholders Equity 16

Balance Sheet 51 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$19.06M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$17.64M	USD	Point-in-time
Tax receivable	`IncomeTaxReceivable`	$25.72K	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	20.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Tax receivable	`IncomeTaxReceivable`	$63.73K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$516.19K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$888.01K	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	13.23M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	13.86M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	13.86M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$18.19M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.01M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	13.23M	shares	Point-in-time
Equipment, net	`PropertyPlantAndEquipmentNet`	$5.70K	USD	Point-in-time
Equipment, net	`PropertyPlantAndEquipmentNet`	$5.08K	USD	Point-in-time
Total assets	`Assets`	$18.19M	USD	Point-in-time
Total assets	`Assets`	$20.02M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$142.94K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$305.68K	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$9.10K	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$9.41K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$50.00K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$50.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$202.04K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$365.09K	USD	Point-in-time
Total liabilities	`Liabilities`	$202.04K	USD	Point-in-time
Total liabilities	`Liabilities`	$365.09K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 10,000,000 and no shares authorized at March 31, 2022 and December 31, 2021, respectively; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 10,000,000 and no shares authorized at March 31, 2022 and December 31, 2021, respectively; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 200,000,000 and 20,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively; 13,858,689 and 13,228,689 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively;	`CommonStockValue`	$1.32K	USD	Point-in-time
Common stock, 200,000,000 and 20,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively; 13,858,689 and 13,228,689 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively;	`CommonStockValue`	$1.39K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$50.60M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$47.62M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$125.41K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$141.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-29.76M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-31.09M	USD	Point-in-time
Stockholders equity	`StockholdersEquity`	$19.65M	USD	Point-in-time
Stockholders equity	`StockholdersEquity`	$17.99M	USD	Point-in-time
Stockholders equity	`StockholdersEquity`	$-4.73M	USD	Point-in-time
Stockholders equity	`StockholdersEquity`	$-5.71M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$20.02M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$18.19M	USD	Point-in-time

Income Statement 30 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	$137.68K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$700.51K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$629.53K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$24.84K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.33M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$162.52K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-162.52K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.33M	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-825.00K	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$388.00	USD	1 Quarter
Interest expense	`InterestExpense`	$27.54K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-852.54K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-388.00	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.02M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.33M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.62K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.59K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.33M	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$15.59K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-9.17K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-9.17K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$15.59K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.32M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.03M	USD	1 Quarter
Loss per common share - basic and diluted	`EarningsPerShareBasic`	$-0.30	USD	1 Quarter
Loss per common share - basic and diluted	`EarningsPerShareBasic`	$-0.10	USD	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	3.38M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	13.83M	shares	1 Quarter

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.33M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$4.25K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$65.07K	USD	1 Quarter
Convertible note issued in exchange for services	`ConvertibleNoteIssuedInExchangeForServices`	-	USD	1 Quarter
Convertible note issued in exchange for services	`ConvertibleNoteIssuedInExchangeForServices`	$60.00K	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-825.00K	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$1.69K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Depreciation	`Depreciation`	$620.00	USD	1 Quarter
Depreciation	`Depreciation`	$608.00	USD	1 Quarter
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$35.96K	USD	1 Quarter
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$25.49K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$353.74K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-293.00	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-141.99K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$160.93K	USD	1 Quarter
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$308.00	USD	1 Quarter
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$25.85K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.49M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-266.45K	USD	1 Quarter
Purchase of equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$802.00	USD	1 Quarter
Purchase of equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-802.00	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Proceeds from convertible notes payable	`ProceedsFromNotesPayable`	-	USD	1 Quarter
Proceeds from convertible notes payable	`ProceedsFromNotesPayable`	$100.00K	USD	1 Quarter
Payments of deferred offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	$35.00K	USD	1 Quarter
Payments of deferred offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	1 Quarter
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$2.91M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$65.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.91M	USD	1 Quarter
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-2.72K	USD	1 Quarter
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-8.04K	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-210.29K	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.42M	USD	1 Quarter
Cash beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.64M	USD	Point-in-time
Cash beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$180.79K	USD	Point-in-time
Cash beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$19.06M	USD	Point-in-time
Cash beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$391.09K	USD	Point-in-time
Cash end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.64M	USD	Point-in-time
Cash end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$180.79K	USD	Point-in-time
Cash end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$19.06M	USD	Point-in-time
Cash end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$391.09K	USD	Point-in-time
Interest paid	`InterestPaidNet`	-	USD	1 Quarter
Interest paid	`InterestPaidNet`	$80.00	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Relative fair value of warrants issued in connection with convertible debt	`RelativeFairValueOfWarrantsIssuedInConnectionWithConvertibleDebt`	-	USD	1 Quarter
Relative fair value of warrants issued in connection with convertible debt	`RelativeFairValueOfWarrantsIssuedInConnectionWithConvertibleDebt`	$42.76K	USD	1 Quarter
Debt discount related to derivative liabilities	`DebtDiscountRelatedToDerivativeLiabilities`	-	USD	1 Quarter
Debt discount related to derivative liabilities	`DebtDiscountRelatedToDerivativeLiabilities`	$50.00K	USD	1 Quarter

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$19.65M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$17.99M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-4.73M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-5.71M	USD	Point-in-time
Shares issued for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$2.91M	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$65.07K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.25K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.33M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-9.17K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$15.59K	USD	1 Quarter
Relative fair value of warrants issued in connection with debt	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$42.76K	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$19.65M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$17.99M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-4.73M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-5.71M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.